Many human thrombi lyse spontaneously without the administration of lytic d
rugs and cause no clinical symptoms. The mechanisms by which this occurs ar
e incompletely understood. We found that model thrombi prepared from whole
human blood in a Chandler loop also exhibited significant spontaneous lysis
. Lysis was inhibited by chemical protease inhibitors, consistent with prot
eolysis resulting primarily from serine proteases, with a small contributio
n from matrix metalloproteinases. Whole blood was fractionated into platele
t-rich plasma and cell populations. Significant spontaneous lysis was obser
ved in platelet-rich thrombi enriched with polymorphonuclear leucocytes (PM
Ns), whereas mononuclear cells (MCs) and erythrocytes did not contribute to
lysis. Incorporation of antibodies to urokinase (u-PA) and its receptor u-
PAR neutralized a large proportion of the activity. Incubation of plasma wi
th PMNs generated free u-PA activity, which was also detectable in model th
rombi and in vivo human thrombi. Purified neutrophils, free of eosinophils,
generated activity identical to PMNs. Smaller contributions to lysis by ti
ssue-type plasminogen activator (t-PA). elastase and cathepsin G were also
identified. These findings suggest a major role for circulating PMNs in end
ogenous thrombus lysis.